Altered Insulin-Like Growth Factor binding Proteins

dc.contributor.assigneeUniversity of Adelaide
dc.contributor.authorForbes, B.
dc.contributor.otherFoley & Lardner LLP
dc.date.issued2009
dc.descriptionPATENT: B. Forbes (Assignee: University of Adelaide). US 7488798 (PCT/AU03/00898) filed Jul 11, 2003; published Feb 10, 2009; predicted expiry Jul 11, 2023.
dc.description.abstractAltered IGFBPs are able to bind IGF, but the release is inhibited by resistance to protease cleavage and/or reduced binding to extracellular matrix (ECM). Alterations have been made in IGFBP-2 to the linker domain in particular and to two amino acid motifs found to be important for ECM binding. IGF-1 mediated proliferation of cancer cells have been inhibited by use of the altered IGFBPs.
dc.description.statementofresponsibilityInventor B. Forbes; Assigned to University of Adelaide; Foley & Lardner LLP agents for inventor.
dc.description.urihttp://www.patentlens.net/patentlens/patent/US_7488798/en/
dc.identifier.patent7488798
dc.identifier.urihttp://hdl.handle.net/2440/74682
dc.language.isoen
dc.subjectUS 7488798
dc.subjectPCT/AU03/00898
dc.titleAltered Insulin-Like Growth Factor binding Proteins
dc.typePatent
pubs.publication-statusPublished

Files